Contraceptive prevalence, any modern method in Niger
Niger: Contraceptive prevalence, any modern method was 11.1% in 2023. ▲ Rising
Contraceptive prevalence, any modern method in Niger, 1992–2023
Source: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division. Measured in % of all women ages 15-49.
Analysis
In 2023, contraceptive prevalence, any modern method in Niger stood at 11.1%.
That represents a change of up 0.9% over ten years.
Over the whole period, contraceptive prevalence, any modern method in Niger peaked at 15.3% in 2017 and was at its lowest, 2.3%, in 1992.
That places Niger 62nd out of 62 countries with data for 2023, putting it in the bottom quarter.
The long-run direction has been consistently rising across the 11 years of available data.
Contraceptive prevalence, any modern method in Niger, year by year
| Year | % of all women ages 15-49 | Change |
|---|---|---|
| 1992 | 2.3% | — |
| 1998 | 4.4% | +91.3% |
| 2000 | 10.2% | +131.0% |
| 2006 | 4.5% | -55.7% |
| 2012 | 11.0% | +144.4% |
| 2015 | 12.1% | +10.0% |
| 2016 | 13.0% | +7.4% |
| 2017 | 15.3% | +17.5% |
| 2021 | 11.4% | -25.0% |
| 2022 | 11.1% | -3.1% |
| 2023 | 11.1% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 3.4% | 2.3% | 4.4% | 2 |
| 2000s | 7.3% | 4.5% | 10.2% | 2 |
| 2010s | 12.8% | 11.0% | 15.3% | 4 |
| 2020s | 11.2% | 11.1% | 11.4% | 3 |
Countries ranked near Niger
More health data for Niger
- Un projection of annual infant deaths, annual growth rate -1.58 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.35 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 887.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 22,995 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 15 (2025)
- Population ages 00-04, female, annual growth rate 2.54 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0865 units per person (2025)
- Population ages 00-04, male, annual growth rate 2.53 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is contraceptive prevalence, any modern method in Niger?
- Contraceptive prevalence, any modern method in Niger was 11.1% in 2023, according to Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.
- What is the highest contraceptive prevalence, any modern method recorded in Niger?
- The highest recorded value was 15.3% in 2017.
- What is the lowest contraceptive prevalence, any modern method recorded in Niger?
- The lowest recorded value was 2.3% in 1992.
- How does Niger rank for contraceptive prevalence, any modern method?
- Niger ranks 62nd out of 62 countries with data for 2023.
- Is contraceptive prevalence, any modern method rising or falling in Niger?
- Over the last ten years it is up 0.9%. The long-run trend across the full record is rising.
- Where does this Niger data come from?
- The figures come from Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as part of Contraceptive prevalence, any modern method (% of all women ages 15-49). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 11 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Contraceptive prevalence, any modern method is the percentage of all women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.